A recent study examined the long-term effects of medical and surgical treatments of T2DM on patient reported outcomes.
STAMPEDE Subanalysis Shows Cardiovascular Benefits After Bariatric Surgery
New details are helping researchers understand precisely why bariatric surgery is associated with a lower risk of CV diseases and events.
Distinctive Dozen: 12 Developments from 2016 Likely to Reshape Cardiovascular Practice
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Bariatric Surgery: Ethical Considerations in Adolescents and Adults with Cognitive Disabilities
Adults without cognitive issues can weigh the risks and benefits, while the issues that arise for adolescents parallel those of adults but tend to be more complex.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Final STAMPEDE Results: Glycemic Benefits of Bariatric Surgery Persist Over Time
Five-year results from the pivotal STAMPEDE trial confirm those of interim reports, with bariatric surgery’s advantage over intensive medical therapy for diabetes appearing to widen over time.
Metabolic Surgery vs. Medical Treatment Improves Libido and Testosterone Levels
Bariatric surgery for weight loss improves symptomatic male hypogonadism in moderately obese men with type 2 diabetes moreso than medical anti-diabetic therapy.
Cleveland Clinic’s 10th Annual Obesity Summit
Attend the 10th Annual Cleveland Clinic Obesity Summit, Oct. 2-3, to hear about progress made in obesity management and to gain insights into surgery, lifestyle interventions, medications and the rise in childhood obesity.
Bariatric Surgery Has Persistent Benefits for Patients with Type 2 Diabetes
A Cleveland Clinic study shows bariatric surgery is a highly effective treatment for type 2 diabetes in obese patients. Results found all participants free of insulin and many free from diabetic drugs 3 years after surgery.